TrialThe Lancet. Infectious diseases2026

Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial.

Adam J Ritchie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.